TY - JOUR
T1 - The levels of oxytocin and oxyntomodulin, adiposity and blood indices in pharmacotherapy naive diabetic and non-diabetic patients with metabolic syndrome
AU - Naserallah, Riham
AU - Kasabri, Violet
AU - Akour, Amal
AU - Khawaja, Nahla
AU - Naffa, Randa
AU - Bustanji, Yasser
N1 - Publisher Copyright:
© 2018 DAR Publishers/The University of Jordan. All Rights Reserved.
PY - 2018
Y1 - 2018
N2 - Aims: Oxyntomodulin (OXM) is a 37-amino acid peptide hormone released from the gut in postprandial state, while oxytocin(OXT) is a nine amino acid neuropeptide produced by the hypothalamus; both has a broad range of actions. Our study aimed to evaluate plasma peptide hormones; OXT and OXM; as well as conicity index (CI), waist circumference (WC), waist circumference to hip circumference ratio (WHR), red cell distribution width (RDW_CV%), mean platelet volume (MPV; fL) and triglyceride to high density lipoprotein-cholesterol (TG\HDL-C) ratio in metabolic syndrome (MetS) and Type-2 diabetes mellitus (T2DM) patients. Methods: In a cross-sectional design, 30 normoglycemic lean subjects (control), 30 MetS and 29 MetS-Pre/T2DM subjects were enrolled. Enzyme-Linked Immunosorbent Assay (ELISA) was used to measure plasma OXT and OXM. The correlations among these metabolic-biomarkers as well as patients’ adiposity and hematological indices were examined. Results: Median circulating levels of OXT (pg/ml) were lower in MetS and MetS-Pre/T2DM compared to control group ((median IQR) (MetS 1975.4and MetS-pre/T2DM 1403 vs. control 4176.6), p=0.009 and p=0.001, respectively). Conversely, median OXM (ng/mL) concentrations lacked any inter-group substantial variations (63023.6 (124670.05-13246.675); for the total study pool of recruits). Neither biomarker was described as substantially different in MetS vs. MetS-pre/T2DM (p>0.05). Principally, in both MetS and MetS-pre/T2DM groups; CI, TG\HDL-C ratio, WC/HC ratio and RDW-CV% were described as markedly higher (p< 0.001) vs. controls’. Median MPV in MetS-pre/T2DM (but not in the nondiabetic MetS group’s) was significantly higher vs. controls’ MPV. However, all above MetS-related indices were not ascribed any statistically pronounced variations in MetS vs. MetS-pre/T2DM groups. Conclusions: In both MetS and MetS-pre/T2DM patients, OXT circulating concentrations were substantially decreased compared to lean controls, while there were not any significant variations in OXM levels between three groups.
AB - Aims: Oxyntomodulin (OXM) is a 37-amino acid peptide hormone released from the gut in postprandial state, while oxytocin(OXT) is a nine amino acid neuropeptide produced by the hypothalamus; both has a broad range of actions. Our study aimed to evaluate plasma peptide hormones; OXT and OXM; as well as conicity index (CI), waist circumference (WC), waist circumference to hip circumference ratio (WHR), red cell distribution width (RDW_CV%), mean platelet volume (MPV; fL) and triglyceride to high density lipoprotein-cholesterol (TG\HDL-C) ratio in metabolic syndrome (MetS) and Type-2 diabetes mellitus (T2DM) patients. Methods: In a cross-sectional design, 30 normoglycemic lean subjects (control), 30 MetS and 29 MetS-Pre/T2DM subjects were enrolled. Enzyme-Linked Immunosorbent Assay (ELISA) was used to measure plasma OXT and OXM. The correlations among these metabolic-biomarkers as well as patients’ adiposity and hematological indices were examined. Results: Median circulating levels of OXT (pg/ml) were lower in MetS and MetS-Pre/T2DM compared to control group ((median IQR) (MetS 1975.4and MetS-pre/T2DM 1403 vs. control 4176.6), p=0.009 and p=0.001, respectively). Conversely, median OXM (ng/mL) concentrations lacked any inter-group substantial variations (63023.6 (124670.05-13246.675); for the total study pool of recruits). Neither biomarker was described as substantially different in MetS vs. MetS-pre/T2DM (p>0.05). Principally, in both MetS and MetS-pre/T2DM groups; CI, TG\HDL-C ratio, WC/HC ratio and RDW-CV% were described as markedly higher (p< 0.001) vs. controls’. Median MPV in MetS-pre/T2DM (but not in the nondiabetic MetS group’s) was significantly higher vs. controls’ MPV. However, all above MetS-related indices were not ascribed any statistically pronounced variations in MetS vs. MetS-pre/T2DM groups. Conclusions: In both MetS and MetS-pre/T2DM patients, OXT circulating concentrations were substantially decreased compared to lean controls, while there were not any significant variations in OXM levels between three groups.
KW - Conicity index (CI)
KW - Oxyntomodulin (OXM)
KW - Oxytocin (OXT)
KW - Red cell distribution width (RDW) and mean platelet volume (MPV)
KW - Triglyceride to high density lipoprotein-cholesterol (TG/HDL-C) ratio
UR - http://www.scopus.com/inward/record.url?scp=85053819376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053819376&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85053819376
SN - 1995-7157
VL - 11
SP - 105
EP - 117
JO - Jordan Journal of Pharmaceutical Sciences
JF - Jordan Journal of Pharmaceutical Sciences
IS - 3
ER -